Clinical Trials
3 trialsNCT02446652 2025-05-29
Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer
National Institute of Cancerología
Phase 3 Withdrawn
NCT00575640 2015-03-04
Hydralazine as a Demethylating Agent in Rectal Cancer
University of Arkansas
Phase 1/2 Withdrawn
NCT00575978 2015-03-04
Hydralazine as Demethylating Agent in Breast Cancer
University of Arkansas
Phase 1/2 Withdrawn